On-Demand Webinars

  1. Sterile Filling Readiness In The Drug Device Delivery Ecosystem 1/14/2026

    Explore how adaptable technologies and strategic partnerships help navigate Annex 1 compliance and technical hurdles to ensure the successful delivery of complex drug products.

  2. Collaborate For Standardization In Large-Volume Subcutaneous Delivery 1/14/2026

    Establishing unified component standards through collaborative innovation eliminates unnecessary investment, reduces development timelines, and ensures scalable, patient-centered delivery systems.

  3. Pfast Protein Expression: A Rapid, Robust Solution For Accelerating Antibody Screening 1/12/2026

    Learn how high-throughput microbial screening identifies optimal expression strains for complex biotherapeutics, significantly reducing the time required to validate computational designs.

  4. Compliance In Conversation: A Fill And Finish Regulatory Roundtable 1/7/2026

    Explore Annex 1 expectations, PFAS legislation, and contamination control strategies in this expert-led discussion, as well as practical insights on risk mitigation, validation, and inspection readiness.

  5. Boost Process Efficiency With Our New mAb Optimized TFF Cassette 1/7/2026

    Discover how optimized membranes and screen designs enable higher mAb concentrations, improved flux performance, and scalability, while addressing TFF process challenges.

  6. Enhancing Automated Environmental Monitoring In Gloveless Isolators 1/7/2026

    Explore how automation and robotic-friendly solutions are transforming fill-and-finish operations and gain insights into gloveless processes, EM testing challenges, and collaborative innovations.

  7. The Impact Of PEGs In The Small Molecule API Market 12/22/2025

    Explore how PEG selection shapes drug development success by understanding the benefits of expert CDMO partnerships that deliver custom solutions to enhance your small molecule program.

  8. Five Practical Considerations To Move From Concept To Clinic 12/17/2025

    Learn more about five key factors for advancing targeted in vivo LNP programs, from formulation and targeting strategies to bioanalytical readiness and scalability.

  9. Agile Adaptation In mRNA-LNP Manufacturing: A CDMO's Response 12/17/2025

    Find flexible scale-up from lab through commercial manufacturing, leveraging expertise. Gain technical insights for scalable, efficient development for advancing mRNA, saRNA, or circular RNA programs.

  10. Overcoming Regulatory Hurdles In AAV Production 12/16/2025

    Demonstrating residual reagent clearance is a critical regulatory requirement in AAV manufacturing. Explore how specialized assays and strategic partnerships streamline compliance.